Cargando…
An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial
BACKGROUND: Organ dysfunction consequent to infection (‘severe sepsis’) is the leading cause of admission to an intensive care unit (ICU). In both animal models and early clinical studies the calcium channel sensitizer levosimendan has been demonstrated to have potentially beneficial effects on orga...
Autores principales: | Orme, Robert M L’E, Perkins, Gavin D, McAuley, Daniel F, Liu, Kathleen D, Mason, Alexina J, Morelli, Andrea, Singer, Mervyn, Ashby, Deborah, Gordon, Anthony C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061524/ https://www.ncbi.nlm.nih.gov/pubmed/24894386 http://dx.doi.org/10.1186/1745-6215-15-199 |
Ejemplares similares
-
Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH)
por: Gordon, Anthony C, et al.
Publicado: (2014) -
Dose–Volume Constraints fOr oRganS At risk In Radiotherapy (CORSAIR): An “All-in-One” Multicenter–Multidisciplinary Practical Summary
por: Bisello, Silvia, et al.
Publicado: (2022) -
Inotropic Support in the Treatment of Septic Myocardial Dysfunction: Pathophysiological Implications Supporting the Use of Levosimendan
por: Morelli, A., et al.
Publicado: (2014) -
High-frequency oscillatory ventilation for PARDS: awaiting PROSPect
por: Kneyber, Martin C. J., et al.
Publicado: (2020) -
Impact of HFOV in pARDS outcomes: questions remain
por: Kanthimathinathan, Hari Krishnan, et al.
Publicado: (2020)